| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GPI anchor binding | 7.31e-05 | 23 | 199 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | sialic acid binding | 1.03e-04 | 25 | 199 | 4 | GO:0033691 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 2.01e-04 | 12 | 199 | 3 | GO:0002162 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | SLK CEACAM6 CLASP2 ITGBL1 PTPRA ADAMTS9 FMN1 DMD CX3CL1 VCAM1 L1CAM TNXB EPHA1 | 2.49e-06 | 270 | 200 | 13 | GO:0007160 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | SLK CEACAM6 CLASP2 ITGBL1 PTPRA ADAMTS9 FMN1 DMD CX3CL1 VCAM1 FOXF1 TBCD L1CAM RADIL TNXB EPHA1 | 2.68e-06 | 410 | 200 | 16 | GO:0031589 |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 3.70e-06 | 25 | 200 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | SLK CEACAM5 PSG9 CEACAM6 CLASP2 ITPKB FBXO38 SERPINE2 PTPRA PTPRG FMN1 FES DMD CX3CL1 VCAM1 FOXF1 TBCD DSCAM L1CAM XBP1 ZBTB7B SCRIB TNXB PRLR EPHA1 | 3.78e-06 | 927 | 200 | 25 | GO:0030155 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.13e-05 | 31 | 200 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CEACAM5 PSG9 CEACAM6 CLSTN2 PTPRG SDK2 DSCAM L1CAM PCDH20 CDH3 | 1.50e-05 | 187 | 200 | 10 | GO:0007156 |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.36e-05 | 18 | 200 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 3.21e-05 | 126 | 200 | 8 | GO:1903035 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | SLK CEACAM6 CLASP2 PTPRA FMN1 DMD CX3CL1 FOXF1 TBCD L1CAM EPHA1 | 3.99e-05 | 254 | 200 | 11 | GO:0010810 |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 4.32e-05 | 66 | 200 | 6 | GO:0010543 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | BOC CEACAM5 PSG9 CEACAM6 CLSTN2 ADGRV1 ITPKB FBXO38 ITGBL1 SERPINE2 PTPRG NRXN2 CX3CL1 VCAM1 FOXF1 SDK2 DSCAM L1CAM XBP1 ZBTB7B PCDH20 IGDCC4 SCRIB CDH3 TNXB | 4.74e-05 | 1077 | 200 | 25 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 4.76e-05 | 98 | 200 | 7 | GO:0061045 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 5.47e-05 | 22 | 200 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CEACAM5 PSG9 CEACAM6 CLSTN2 PTPRG CX3CL1 VCAM1 SDK2 DSCAM L1CAM PCDH20 CDH3 | 5.82e-05 | 313 | 200 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 6.57e-05 | 23 | 200 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of cell-matrix adhesion | 7.15e-05 | 141 | 200 | 8 | GO:0001952 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 8.07e-05 | 228 | 200 | 10 | GO:0046777 | |
| GeneOntologyBiologicalProcess | lactation | 9.95e-05 | 48 | 200 | 5 | GO:0007595 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | CEACAM5 ATP7B PDGFA PSG9 CEACAM6 F5 HEG1 SERPINE2 GP1BB VIP CAD XBP1 ZBTB7B PRLR | 1.11e-04 | 442 | 200 | 14 | GO:0050878 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.46e-04 | 28 | 200 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | mammary gland development | 1.88e-04 | 162 | 200 | 8 | GO:0030879 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 2.22e-04 | 166 | 200 | 8 | GO:0061041 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | CEACAM5 PDGFA PSG9 CEACAM6 CLASP2 SERPINE2 SIGLEC16 XBP1 MUC16 | 2.78e-04 | 217 | 200 | 9 | GO:1903034 |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.82e-04 | 33 | 200 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.89e-04 | 60 | 200 | 5 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 3.02e-04 | 14 | 200 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | wound healing | CEACAM5 PDGFA PSG9 CEACAM6 CLASP2 F5 SERPINE2 PLEC CX3CL1 GP1BB XBP1 MUC16 SCRIB GRHL3 | 3.40e-04 | 493 | 200 | 14 | GO:0042060 |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.75e-04 | 15 | 200 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 3.75e-04 | 15 | 200 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.75e-04 | 15 | 200 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.75e-04 | 15 | 200 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | visual perception | 4.25e-04 | 230 | 200 | 9 | GO:0007601 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 4.58e-04 | 16 | 200 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 4.67e-04 | 233 | 200 | 9 | GO:0050953 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 4.89e-04 | 38 | 200 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | cell junction organization | SLK CEACAM5 CTTNBP2 PSG9 CEACAM6 CLASP2 CLSTN2 LRIT3 HEG1 PTPRA NRXN2 FMN1 GLRB PLEC CX3CL1 TBCD SDK2 DSCAM L1CAM NCAN CDH3 | 5.28e-04 | 974 | 200 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | CEACAM5 PSG9 CEACAM6 ITPKB FBXO38 FMN1 DMD CX3CL1 VCAM1 FOXF1 L1CAM XBP1 ZBTB7B TNXB EPHA1 | 5.49e-04 | 579 | 200 | 15 | GO:0045785 |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 5.52e-04 | 17 | 200 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 5.52e-04 | 17 | 200 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 5.52e-04 | 17 | 200 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 5.54e-04 | 69 | 200 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-matrix adhesion | 5.54e-04 | 69 | 200 | 5 | GO:0001954 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 5.92e-04 | 70 | 200 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 5.97e-04 | 40 | 200 | 4 | GO:0045953 | |
| GeneOntologyCellularComponent | cell surface | BOC CEACAM5 PDGFA PSG9 CEACAM6 CLSTN2 ADGRV1 ITGBL1 BTN3A3 HEG1 ADAMTS9 GLRB NCR2 DMD CX3CL1 VCAM1 FLT3 VASN L1CAM MUC16 BTN3A2 LIFR ADAMTS7 CLEC14A DNAI2 FCRL5 SLC24A1 PRLR | 2.43e-06 | 1111 | 199 | 28 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | CEACAM5 PSG9 CEACAM6 BTN3A3 HEG1 GLRB VCAM1 FLT3 L1CAM MUC16 BTN3A2 LIFR CLEC14A DNAI2 FCRL5 PRLR | 3.97e-05 | 519 | 199 | 16 | GO:0009897 |
| GeneOntologyCellularComponent | side of membrane | CEACAM5 PSG9 CEACAM6 BTN3A3 HEG1 GBP5 ALG14 GLRB FES DMD VCAM1 FLT3 L1CAM MUC16 BTN3A2 LIFR CLEC14A DNAI2 FCRL5 AP4B1 PRLR | 9.72e-05 | 875 | 199 | 21 | GO:0098552 |
| GeneOntologyCellularComponent | adherens junction | 2.04e-04 | 212 | 199 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.21e-04 | 90 | 199 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 4.34e-04 | 16 | 199 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | syntrophin complex | 5.34e-04 | 4 | 199 | 2 | GO:0016013 | |
| Domain | Ig-like_fold | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 CAMTA2 LRIT3 TGM5 BTN3A3 PTPRG NCR2 KIR2DL4 VCAM1 SEMA4B LILRB3 FLT3 SDK2 DSCAM VASN L1CAM LILRA6 SIGLEC14 VWA1 BTN3A2 IGDCC4 IFNGR2 LIFR NCAN FCRL5 TNXB PRLR EPHA1 | 2.21e-12 | 706 | 195 | 32 | IPR013783 |
| Domain | - | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 LRIT3 TGM5 BTN3A3 PTPRG NCR2 KIR2DL4 VCAM1 FLT3 SDK2 DSCAM VASN L1CAM SIGLEC14 VWA1 BTN3A2 IGDCC4 IFNGR2 LIFR NCAN FCRL5 TNXB PRLR EPHA1 | 3.09e-10 | 663 | 195 | 28 | 2.60.40.10 |
| Domain | IG | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 LRIT3 BTN3A3 NCR2 KIR2DL4 VCAM1 LILRB3 FLT3 SDK2 DSCAM L1CAM LILRA6 SIGLEC14 BTN3A2 IGDCC4 NCAN FCRL5 | 3.40e-09 | 421 | 195 | 21 | SM00409 |
| Domain | Ig_sub | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 LRIT3 BTN3A3 NCR2 KIR2DL4 VCAM1 LILRB3 FLT3 SDK2 DSCAM L1CAM LILRA6 SIGLEC14 BTN3A2 IGDCC4 NCAN FCRL5 | 3.40e-09 | 421 | 195 | 21 | IPR003599 |
| Domain | FN3 | BOC LRIT3 PTPRG SDK2 DSCAM VASN L1CAM VWA1 IGDCC4 IFNGR2 LIFR TNXB PRLR EPHA1 | 9.16e-09 | 185 | 195 | 14 | SM00060 |
| Domain | ig | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 KIR2DL4 VCAM1 LILRB3 FLT3 SDK2 DSCAM LILRA6 SIGLEC14 FCRL5 | 1.29e-08 | 190 | 195 | 14 | PF00047 |
| Domain | Immunoglobulin | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 KIR2DL4 VCAM1 LILRB3 FLT3 SDK2 DSCAM LILRA6 SIGLEC14 FCRL5 | 1.29e-08 | 190 | 195 | 14 | IPR013151 |
| Domain | fn3 | BOC PTPRG SDK2 DSCAM VASN L1CAM VWA1 IGDCC4 IFNGR2 LIFR TNXB PRLR EPHA1 | 1.56e-08 | 162 | 195 | 13 | PF00041 |
| Domain | FN3 | BOC LRIT3 PTPRG SDK2 DSCAM VASN L1CAM VWA1 IGDCC4 IFNGR2 LIFR TNXB PRLR EPHA1 | 2.32e-08 | 199 | 195 | 14 | PS50853 |
| Domain | FN3_dom | BOC LRIT3 PTPRG SDK2 DSCAM VASN L1CAM VWA1 IGDCC4 IFNGR2 LIFR TNXB PRLR EPHA1 | 4.31e-08 | 209 | 195 | 14 | IPR003961 |
| Domain | IG_LIKE | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 LRIT3 BTN3A3 NCR2 KIR2DL4 VCAM1 LILRB3 FLT3 SDK2 DSCAM L1CAM LILRA6 SIGLEC14 BTN3A2 IGDCC4 NCAN FCRL5 | 4.91e-08 | 491 | 195 | 21 | PS50835 |
| Domain | Ig-like_dom | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 LRIT3 BTN3A3 NCR2 KIR2DL4 VCAM1 LILRB3 FLT3 SDK2 DSCAM L1CAM LILRA6 SIGLEC14 BTN3A2 IGDCC4 NCAN FCRL5 | 7.39e-08 | 503 | 195 | 21 | IPR007110 |
| Domain | IGc2 | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 LRIT3 VCAM1 SDK2 DSCAM L1CAM SIGLEC14 IGDCC4 FCRL5 | 1.18e-06 | 235 | 195 | 13 | SM00408 |
| Domain | Ig_sub2 | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 LRIT3 VCAM1 SDK2 DSCAM L1CAM SIGLEC14 IGDCC4 FCRL5 | 1.18e-06 | 235 | 195 | 13 | IPR003598 |
| Domain | Ig_V-set | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 BTN3A3 NCR2 VCAM1 DSCAM SIGLEC14 BTN3A2 NCAN | 1.25e-06 | 199 | 195 | 12 | IPR013106 |
| Domain | V-set | BOC CEACAM5 PSG9 CEACAM6 SIGLEC5 BTN3A3 NCR2 VCAM1 SIGLEC14 BTN3A2 NCAN | 3.81e-06 | 184 | 195 | 11 | PF07686 |
| Domain | Ig_I-set | BOC CEACAM5 CEACAM6 LRIT3 VCAM1 SDK2 DSCAM L1CAM SIGLEC14 IGDCC4 | 3.19e-05 | 190 | 195 | 10 | IPR013098 |
| Domain | I-set | BOC CEACAM5 CEACAM6 LRIT3 VCAM1 SDK2 DSCAM L1CAM SIGLEC14 IGDCC4 | 3.19e-05 | 190 | 195 | 10 | PF07679 |
| Domain | HEAT_REPEAT | 9.03e-05 | 70 | 195 | 6 | PS50077 | |
| Domain | Tankyrase-bd_C | 1.08e-04 | 2 | 195 | 2 | IPR032764 | |
| Domain | Tankyrase_bdg_C | 1.08e-04 | 2 | 195 | 2 | SM01319 | |
| Domain | Tankyrase_bdg_C | 1.08e-04 | 2 | 195 | 2 | PF15327 | |
| Domain | HEAT | 3.45e-04 | 58 | 195 | 5 | IPR000357 | |
| Pubmed | BOC CEACAM5 PSG9 CEACAM6 LRIT3 PTPRA SEMA4B FLT3 DSCAM VASN IGDCC4 | 3.94e-09 | 162 | 206 | 11 | 25826454 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ANKS6 KMT2B CLASP2 FASN HEG1 PLEC TBCD SEMA4F SEMA4B GTSE1 L1CAM KSR2 BTN3A2 RADIL GAREM2 ADAMTS7 TTLL4 PCNX1 TNKS1BP1 PAX2 C3orf18 SLC45A1 MAPKBP1 | 2.01e-07 | 1105 | 206 | 23 | 35748872 |
| Pubmed | Insulin acutely decreases hepatic fatty acid synthase activity. | 1.55e-06 | 15 | 206 | 4 | 16054098 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | SLK DLGAP5 FASN PRRC2C PLEC GTSE1 DENND4C SPAG5 TNKS1BP1 SCRIB | 3.37e-06 | 256 | 206 | 10 | 33397691 |
| Pubmed | DLGAP5 ADGRV1 RGP1 NRXN2 AP5Z1 PAN2 SDK2 KIAA1549 FMNL3 IBTK TTLL4 PCNX1 TNKS1BP1 KDM4B | 3.78e-06 | 529 | 206 | 14 | 14621295 | |
| Pubmed | 4.04e-06 | 6 | 206 | 3 | 14559209 | ||
| Pubmed | CLASP2 UBR5 LRCH2 DENND4C SPAG5 KIAA1671 IBTK TNKS1BP1 SCRIB | 4.78e-06 | 209 | 206 | 9 | 36779422 | |
| Pubmed | SLK CTTNBP2 DLGAP5 ZMYM2 CLASP2 GIT2 RCOR2 ITIH4 UBR5 PRRC2C NCOA2 CAD LRCH2 DSCAM KSR2 NCAN CCAR1 QSER1 SCRIB | 5.28e-06 | 963 | 206 | 19 | 28671696 | |
| Pubmed | 7.04e-06 | 7 | 206 | 3 | 20805509 | ||
| Pubmed | PCYT1A DLGAP5 MAP3K20 ZMYM2 FASN PAN2 CAD GTSE1 FCHO2 DENND4C TNKS1BP1 SCRIB EPHA1 | 1.09e-05 | 503 | 206 | 13 | 16964243 | |
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 1.37e-05 | 25 | 206 | 4 | 38687251 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 24799499 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 23941132 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 38383657 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 24680660 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 7513709 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 25470546 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 12713735 | ||
| Pubmed | Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. | 3.49e-05 | 2 | 206 | 2 | 17201906 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 15130118 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 2317824 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 34801967 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 3220478 | ||
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 3.49e-05 | 2 | 206 | 2 | 33526815 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 35022505 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 16740130 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 26459514 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 38502695 | ||
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 3.49e-05 | 2 | 206 | 2 | 36449053 | |
| Pubmed | Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus. | 3.49e-05 | 2 | 206 | 2 | 1373808 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 30785396 | ||
| Pubmed | Expression of trypsin-like proteases and protease nexin-1 in mdx mouse muscles. | 3.49e-05 | 2 | 206 | 2 | 14733957 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 8530023 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 2803308 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 26174230 | ||
| Pubmed | The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase. | 3.49e-05 | 2 | 206 | 2 | 25742604 | |
| Pubmed | Characterization of the L1-neurocan-binding site. Implications for L1-L1 homophilic binding. | 3.49e-05 | 2 | 206 | 2 | 10934197 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 19617579 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 22357859 | ||
| Pubmed | Human carcinoembryonic antigen functions as a general inhibitor of anoikis. | 3.49e-05 | 2 | 206 | 2 | 10910050 | |
| Pubmed | Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. | 3.49e-05 | 2 | 206 | 2 | 22941175 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 31323021 | ||
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 21402792 | ||
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 3.49e-05 | 2 | 206 | 2 | 24096970 | |
| Pubmed | 3.49e-05 | 2 | 206 | 2 | 27095104 | ||
| Pubmed | 4.33e-05 | 12 | 206 | 3 | 18521186 | ||
| Pubmed | KMT2B ZMYM2 RCOR2 FASN UBR5 PLEC DENND4C SPAG5 KIAA1671 TLE1 TNKS1BP1 | 4.43e-05 | 418 | 206 | 11 | 34709266 | |
| Pubmed | 4.82e-05 | 34 | 206 | 4 | 30894540 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 5.61e-05 | 13 | 206 | 3 | 1985902 | |
| Pubmed | CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder. | 5.61e-05 | 13 | 206 | 3 | 35921817 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 5.61e-05 | 13 | 206 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 5.61e-05 | 13 | 206 | 3 | 16638824 | |
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 20044046 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 32150576 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 6265583 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 5.61e-05 | 13 | 206 | 3 | 12832451 | |
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 5.61e-05 | 13 | 206 | 3 | 21670291 | |
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 22162753 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 2702644 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 8380065 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 1279194 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 25724769 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 5.61e-05 | 13 | 206 | 3 | 22092845 | |
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 11801635 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 5.61e-05 | 13 | 206 | 3 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 5.61e-05 | 13 | 206 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 5.61e-05 | 13 | 206 | 3 | 23800882 | |
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 19285068 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 21760897 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 5.61e-05 | 13 | 206 | 3 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 5.61e-05 | 13 | 206 | 3 | 39168268 | |
| Pubmed | Multiple loci influencing hippocampal degeneration identified by genome scan. | 5.61e-05 | 13 | 206 | 3 | 22745009 | |
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 8402684 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 16619040 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 5.61e-05 | 13 | 206 | 3 | 8209741 | |
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 5.61e-05 | 13 | 206 | 3 | 21949477 | |
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 26219866 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 2133556 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 32521208 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 19406938 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 5.61e-05 | 13 | 206 | 3 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 5.61e-05 | 13 | 206 | 3 | 19358828 | |
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 16680193 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 5.61e-05 | 13 | 206 | 3 | 34058224 | |
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 10964771 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 32169849 | ||
| Pubmed | 5.61e-05 | 13 | 206 | 3 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 5.61e-05 | 13 | 206 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 5.61e-05 | 13 | 206 | 3 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 5.61e-05 | 13 | 206 | 3 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 5.61e-05 | 13 | 206 | 3 | 23935487 | |
| GeneFamily | Fibronectin type III domain containing | BOC PTPRG PTPRQ SDK2 DSCAM L1CAM VWA1 IGDCC4 IFNGR2 LIFR TNXB EPHA1 | 2.13e-09 | 160 | 132 | 12 | 555 |
| GeneFamily | Adenosine receptors|V-set domain containing | CEACAM5 PSG9 CEACAM6 SIGLEC5 BTN3A3 NCR2 SIGLEC16 SIGLEC14 BTN3A2 NCAN | 3.27e-07 | 163 | 132 | 10 | 590 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.80e-06 | 161 | 132 | 9 | 593 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | CEACAM5 CEACAM6 SIGLEC5 NCR2 KIR2DL4 VCAM1 GP1BB LILRB3 FLT3 L1CAM LILRA6 LIFR FCRL5 | 6.35e-06 | 394 | 132 | 13 | 471 |
| GeneFamily | Immunoglobulin like domain containing | 1.22e-05 | 193 | 132 | 9 | 594 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.59e-04 | 21 | 132 | 3 | 813 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 1.09e-03 | 28 | 132 | 3 | 745 | |
| GeneFamily | WD repeat domain containing | 3.14e-03 | 262 | 132 | 7 | 362 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | KMT2B ADGRV1 PTPRG FMN1 PRRC2C DMD KIAA1549 ZFC3H1 KIAA1671 RNF220 MCTP1 SLC28A1 CCAR1 PAX2 PRLR | 1.07e-06 | 417 | 204 | 15 | M39224 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | SOX15 CEACAM6 RGS9 ITIH4 HEG1 PLEC NCR2 FOXF1 TBCD PRRX2 SDK2 L1CAM CPT1B VWA7 SKI SLC2A2 ITPKC LDB3 TNXA TNXB EPHA1 | 9.37e-06 | 909 | 204 | 21 | M41018 |
| Coexpression | ESC_J1_UP_EARLY.V1_UP | 1.14e-05 | 178 | 204 | 9 | M2764 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP | 1.76e-05 | 188 | 204 | 9 | M7940 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN | 2.00e-05 | 191 | 204 | 9 | M4222 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 3.55e-05 | 48 | 204 | 5 | MM531 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX15 POLN FOXF1 ADCY4 DSCAM VWA7 KIAA1671 CACNA2D4 CLEC14A PRLR | 1.02e-08 | 176 | 206 | 10 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SOX15 POLN FOXF1 ADCY4 DSCAM VWA7 KIAA1671 CACNA2D4 CLEC14A PRLR | 1.02e-08 | 176 | 206 | 10 | 88ca2f83d8301633232735f39b0683efe49d0b86 |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.91e-08 | 188 | 206 | 10 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | ITPKB HEG1 ADAMTS9 TBCD ADCY4 KIAA1671 ZBTB46 MCTP1 CLEC14A SNTG2 | 2.70e-08 | 195 | 206 | 10 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | ITPKB TBCD ADCY4 KIAA1549 KIAA1671 LIFR ZBTB46 MCTP1 CLEC14A SNTG2 | 2.70e-08 | 195 | 206 | 10 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | HEG1 ADAMTS9 CX3CL1 FOXF1 TBCD ADCY4 VWA1 LIFR MCTP1 CLEC14A | 2.84e-08 | 196 | 206 | 10 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | ITPKB TBCD ADCY4 KIAA1549 KIAA1671 LIFR ZBTB46 MCTP1 CLEC14A SNTG2 | 2.98e-08 | 197 | 206 | 10 | f9731d4d636e51b94a96805eee6afe9aedc175e3 |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-07 | 127 | 206 | 8 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.44e-07 | 188 | 206 | 9 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-07 | 189 | 206 | 9 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-07 | 190 | 206 | 9 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-07 | 190 | 206 | 9 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.91e-07 | 192 | 206 | 9 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.04e-07 | 193 | 206 | 9 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | IPF-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 3.04e-07 | 193 | 206 | 9 | 70a9aadda83a97e06e9bc2d1327ce60dd3c58767 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | ITPKB ADAMTS9 ADCY4 KIAA1671 LIFR ZBTB46 MCTP1 CLEC14A SNTG2 | 3.04e-07 | 193 | 206 | 9 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.04e-07 | 193 | 206 | 9 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | IPF-Endothelial-VE_Arterial|IPF / Disease state, Lineage and Cell class | 3.04e-07 | 193 | 206 | 9 | bf83b1fe9d38408f30eee4eb634341c04ef82791 | |
| ToppCell | Control-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 3.04e-07 | 193 | 206 | 9 | 52c0f2c7af57436f23e0c0e0c87086c47695e2c4 | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | ITPKB ADAMTS9 ADCY4 KIAA1671 LIFR ZBTB46 MCTP1 CLEC14A SNTG2 | 3.18e-07 | 194 | 206 | 9 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 |
| ToppCell | Endothelial-A-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-07 | 194 | 206 | 9 | e656ac5539e59e321b46706cb8cc423b2c3358a0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 194 | 206 | 9 | e8102c8811333f04de7280b7d9b6b85cebb815ac | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 194 | 206 | 9 | 4b0d63babb8a46ff45731d5f82b29ccaf6c9402d | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | SERPINE2 ADAMTS9 CX3CL1 VCAM1 FOXF1 ADCY4 LIFR MCTP1 CLEC14A | 3.46e-07 | 196 | 206 | 9 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.46e-07 | 196 | 206 | 9 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-07 | 197 | 206 | 9 | 8437c33e2c4a10a1b95343431e48d5e820b1f742 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-07 | 197 | 206 | 9 | a6a64581699cfcb9607b288976fa3b09648725b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-07 | 197 | 206 | 9 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-07 | 197 | 206 | 9 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | ITPKB ADAMTS9 TBCD ADCY4 KIAA1671 ZBTB46 MCTP1 CLEC14A SNTG2 | 3.62e-07 | 197 | 206 | 9 | ab6d1ab586a188597a39854ef980b8955ebcc645 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-07 | 197 | 206 | 9 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Endothelial_cells-Endothelial-A|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 3.94e-07 | 199 | 206 | 9 | 2a1424c61ddcd1fea9574f7a3ad1955387458130 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.94e-07 | 199 | 206 | 9 | 6e3a226ebba023e3e909d7a7188137da4f1fd7fc | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.94e-07 | 199 | 206 | 9 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.11e-07 | 200 | 206 | 9 | 84e145619a500530f42ed0fe72468ae95f4cbf1e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.11e-07 | 200 | 206 | 9 | 2ae62c428728c1d9d4471d4be24bd6ab074fa22c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-06 | 170 | 206 | 8 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-06 | 176 | 206 | 8 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-06 | 178 | 206 | 8 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.93e-06 | 179 | 206 | 8 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-06 | 180 | 206 | 8 | efc4c5a4dea456527526bbfd88cf70d803893671 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 2.36e-06 | 184 | 206 | 8 | ee295f6fa898da53883e1358b17f2c2dd177e9a7 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.36e-06 | 184 | 206 | 8 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 2.36e-06 | 184 | 206 | 8 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.46e-06 | 185 | 206 | 8 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-06 | 186 | 206 | 8 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-06 | 186 | 206 | 8 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | COPD-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 2.67e-06 | 187 | 206 | 8 | be42ee71d3412bb1f52593d8814de85c354a0efa | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-06 | 132 | 206 | 7 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.77e-06 | 188 | 206 | 8 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-06 | 188 | 206 | 8 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 3.00e-06 | 190 | 206 | 8 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.00e-06 | 190 | 206 | 8 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.00e-06 | 190 | 206 | 8 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.00e-06 | 190 | 206 | 8 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 3.24e-06 | 192 | 206 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.24e-06 | 192 | 206 | 8 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-06 | 192 | 206 | 8 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.24e-06 | 192 | 206 | 8 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.24e-06 | 192 | 206 | 8 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | 3.37e-06 | 193 | 206 | 8 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.37e-06 | 193 | 206 | 8 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.37e-06 | 193 | 206 | 8 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.37e-06 | 193 | 206 | 8 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 3.37e-06 | 193 | 206 | 8 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 3.37e-06 | 193 | 206 | 8 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 3.50e-06 | 194 | 206 | 8 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.64e-06 | 195 | 206 | 8 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.64e-06 | 195 | 206 | 8 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | LAM-Endothelial-VasEndo-2|LAM / Condition, Lineage and Cell class | 3.64e-06 | 195 | 206 | 8 | bd11d771938251c091a50d559a2c38d1c4a04033 | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 3.78e-06 | 196 | 206 | 8 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-06 | 197 | 206 | 8 | 0542badae77d2f606c13cfaf361319495c354351 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-06 | 197 | 206 | 8 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-06 | 197 | 206 | 8 | c29ed0e706999d4c2b93e6e3bf46c42aeceb4813 | |
| ToppCell | Endothelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 4.07e-06 | 198 | 206 | 8 | b93effa428ec036542fa21647dfef9589c64640f | |
| ToppCell | Endothelial-A|World / lung cells shred on cell class, cell subclass, sample id | 4.07e-06 | 198 | 206 | 8 | dd096d4b9f428615f927f7df7cbf5cede0e0e605 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.07e-06 | 198 | 206 | 8 | d73585a5587941483db8d9ddc2d68f7d852bbbc8 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.07e-06 | 198 | 206 | 8 | e9e98c20ff7b3f3851db86381550ce7085e2db9e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.07e-06 | 198 | 206 | 8 | 531b0f88c95f813e3914c96749f591e80ca321d0 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.22e-06 | 199 | 206 | 8 | d359f3e1595ba8d8a3dc9eb2e8f2b61f3247c7a1 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-NK_CD56bright|IIF / Disease, condition lineage and cell class | 4.22e-06 | 199 | 206 | 8 | 9eb2b7d4900b118338590db778a47504559e228d | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-06 | 200 | 206 | 8 | 9f889f7ff0b3ba2750aa757b94680a9f7014fd0d | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.38e-06 | 200 | 206 | 8 | 71979bbcc035d5b8882f1502b5a8ef248aaba45a | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.38e-06 | 200 | 206 | 8 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 4.38e-06 | 200 | 206 | 8 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.38e-06 | 200 | 206 | 8 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Biopsy_Other_PF-Endothelial-Endothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.38e-06 | 200 | 206 | 8 | 40d57a383c79d3365e033d08efd9371f0bc5bf55 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-06 | 200 | 206 | 8 | 06ffa5baad3e699cf66d8b2c7513649e1d2c7e62 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Bronchial_vessel-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.38e-06 | 200 | 206 | 8 | c55efd997392e99068b673542f56f1a209c5a6c8 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Bronchial_vessel|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.38e-06 | 200 | 206 | 8 | a18817d36b2b30a32e1513d36174bf98dfea2a92 | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.38e-06 | 200 | 206 | 8 | 663e2b4672f193844bb9bf4873749114977c19b3 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-06 | 150 | 206 | 7 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-05 | 163 | 206 | 7 | 510c0af66e82c5a8cf8edd0547dae4018a87dbbf | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-05 | 163 | 206 | 7 | 99cf60dc87f7ce288553091bffcd85109a02bd8f | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 1.20e-05 | 165 | 206 | 7 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 166 | 206 | 7 | c0af93db981dfd448abc7efcd257f3e5ff066aae | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.40e-05 | 169 | 206 | 7 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-05 | 172 | 206 | 7 | cf46810dd1072b6f2171e5d9530351ddc79a055b | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 1.63e-05 | 173 | 206 | 7 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | Control-Lymphocyte-T_NK-gdT|Control / Disease, Lineage and Cell Type | 1.69e-05 | 174 | 206 | 7 | 202d222a53f967cce172e5f3f1b40920ea13ec6c | |
| Disease | Nephronophthisis, familial juvenile | 1.07e-05 | 7 | 201 | 3 | C1855681 | |
| Disease | Night blindness, congenital stationary | 1.97e-04 | 17 | 201 | 3 | C0339535 | |
| Disease | forced expiratory volume, response to bronchodilator | CLSTN2 ADGRV1 NRXN2 PLEC KSR2 LDB3 MCTP1 ADAMTS7 TLE1 SNTG2 PRLR | 2.57e-04 | 445 | 201 | 11 | EFO_0004314, GO_0097366 |
| Disease | X-22162 measurement | 2.75e-04 | 4 | 201 | 2 | EFO_0800839 | |
| Disease | Malignant neoplasm of breast | BOC ATP7B PDGFA EOMES PIK3R4 FASN SERPINE2 DMD NCOA2 ABCC1 XBP1 BTN3A2 PCDH20 SLC2A2 ABCB8 SLC28A1 FCRL5 VPS13B | 4.26e-04 | 1074 | 201 | 18 | C0006142 |
| Disease | Wilson disease (implicated_via_orthology) | 4.56e-04 | 5 | 201 | 2 | DOID:893 (implicated_via_orthology) | |
| Disease | 2'-O-methyluridine measurement | 4.56e-04 | 5 | 201 | 2 | EFO_0800636 | |
| Disease | intermediate coronary syndrome (is_implicated_in) | 4.56e-04 | 5 | 201 | 2 | DOID:8805 (is_implicated_in) | |
| Disease | immunoglobulin superfamily DCC subclass member 4 measurement | 4.56e-04 | 5 | 201 | 2 | EFO_0801690 | |
| Disease | Disorder of eye | 6.54e-04 | 212 | 201 | 7 | C0015397 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 6.80e-04 | 6 | 201 | 2 | EFO_0802705 | |
| Disease | parenchymal hematoma, response to recombinant tissue-plasminogen activator | 6.80e-04 | 6 | 201 | 2 | EFO_0020101, EFO_0600080 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 6.80e-04 | 6 | 201 | 2 | EFO_0801767 | |
| Disease | Liver carcinoma | KMT2B DLGAP5 HMGCR FASN NLRC3 VCAM1 VASN GTSE1 SLC2A2 GBA3 LIFR | 7.62e-04 | 507 | 201 | 11 | C2239176 |
| Disease | periodontitis | 8.80e-04 | 223 | 201 | 7 | EFO_0000649 | |
| Disease | wellbeing measurement | ANKS6 CTTNBP2 FASN PTPRG PTPRQ SLC27A2 DSCAM POM121L2 ODAD2 MON1B BTN3A2 UBE3D TNXB | 9.82e-04 | 692 | 201 | 13 | EFO_0007869 |
| Disease | Colorectal Carcinoma | MKRN3 BOC ATP7B CLSTN2 F5 PAN2 DMD ABCC1 CAD LIFR RHPN2 CCAR1 EPHA1 | 1.12e-03 | 702 | 201 | 13 | C0009402 |
| Disease | calcium measurement | CPA4 ZMYM2 HMGCR ITPKB PLEC PARM1 PYROXD2 SIGLEC14 FCHO2 LHFPL7 PLEKHO1 EPHA1 | 1.33e-03 | 628 | 201 | 12 | EFO_0004838 |
| Disease | lung carcinoma | 1.83e-03 | 482 | 201 | 10 | EFO_0001071 | |
| Disease | cup-to-disc ratio measurement, optic cup area measurement, optic disc area measurement | 2.00e-03 | 10 | 201 | 2 | EFO_0006937, EFO_0006939, EFO_0006940 | |
| Disease | Anemia, Sickle Cell | 2.00e-03 | 10 | 201 | 2 | C0002895 | |
| Disease | Muscle Weakness | 2.00e-03 | 10 | 201 | 2 | C0151786 | |
| Disease | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement | 2.00e-03 | 10 | 201 | 2 | EFO_0801544 | |
| Disease | cortical surface area measurement | CPA4 CTTNBP2 DCDC1 HMGCR ADGRV1 RGP1 MTMR11 ADAMTS9 PRRC2C FES USP35 NCOA2 FCHO2 ADAMTS7 CCAR1 PAX2 QSER1 TNXB PRLR | 2.21e-03 | 1345 | 201 | 19 | EFO_0010736 |
| Disease | nucleus accumbens volume change measurement | 2.44e-03 | 11 | 201 | 2 | EFO_0021493 | |
| Disease | age at menarche | MKRN3 PTPRG USP35 FLT3 DSCAM PCDH20 ZBTB46 PAX2 GREB1 SLX4 KDM4B | 2.66e-03 | 594 | 201 | 11 | EFO_0004703 |
| Disease | Profound Mental Retardation | 2.69e-03 | 139 | 201 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.69e-03 | 139 | 201 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.69e-03 | 139 | 201 | 5 | C0917816 | |
| Disease | sialic acid-binding Ig-like lectin 14 measurement | 2.91e-03 | 12 | 201 | 2 | EFO_0008284 | |
| Disease | Night blindness, congenital stationary, type 1 | 2.91e-03 | 12 | 201 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 2.91e-03 | 12 | 201 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 2.91e-03 | 12 | 201 | 2 | C1864877 | |
| Disease | killer cell immunoglobulin-like receptor 2DL4 measurement | 2.91e-03 | 12 | 201 | 2 | EFO_0008197 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 2.91e-03 | 12 | 201 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 2.91e-03 | 12 | 201 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 2.91e-03 | 12 | 201 | 2 | C1848172 | |
| Disease | pulmonary embolism (biomarker_via_orthology) | 2.91e-03 | 12 | 201 | 2 | DOID:9477 (biomarker_via_orthology) | |
| Disease | beta-nerve growth factor measurement | 2.94e-03 | 42 | 201 | 3 | EFO_0008035 | |
| Disease | Fatty Liver | 3.12e-03 | 88 | 201 | 4 | C0015695 | |
| Disease | Steatohepatitis | 3.12e-03 | 88 | 201 | 4 | C2711227 | |
| Disease | Sclerocystic Ovaries | 3.13e-03 | 144 | 201 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 3.13e-03 | 144 | 201 | 5 | C0032460 | |
| Disease | esophageal squamous cell carcinoma | 3.43e-03 | 13 | 201 | 2 | EFO_0005922 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 3.43e-03 | 13 | 201 | 2 | C4041558 | |
| Disease | nevus count, cutaneous melanoma | 3.52e-03 | 91 | 201 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | sexual dimorphism measurement | KMT2B HMGCR RGP1 PRAM1 MTMR11 PTPRG PLEC ADCY4 POM121L2 TEAD3 BTN3A2 ZBTB46 PAX2 C3orf18 MAPKBP1 POLG2 | 3.89e-03 | 1106 | 201 | 16 | EFO_0021796 |
| Disease | colorectal cancer, colorectal adenoma | 3.94e-03 | 152 | 201 | 5 | EFO_0005406, MONDO_0005575 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.98e-03 | 14 | 201 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Gastrointestinal Stromal Sarcoma | 4.05e-03 | 47 | 201 | 3 | C3179349 | |
| Disease | Alzheimer disease, dementia, family history of Alzheimer’s disease | 4.30e-03 | 48 | 201 | 3 | EFO_0009268, MONDO_0001627, MONDO_0004975 | |
| Disease | Kidney Failure, Chronic | 4.30e-03 | 48 | 201 | 3 | C0022661 | |
| Disease | Gastrointestinal Stromal Tumors | 4.82e-03 | 50 | 201 | 3 | C0238198 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 5.20e-03 | 16 | 201 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | coronary thrombosis, GM11992 | 5.20e-03 | 16 | 201 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 5.20e-03 | 16 | 201 | 2 | C0334634 | |
| Disease | Polyposis, Adenomatous Intestinal | 5.20e-03 | 16 | 201 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 5.20e-03 | 16 | 201 | 2 | C2713443 | |
| Disease | succinylcarnitine measurement | 5.20e-03 | 16 | 201 | 2 | EFO_0020020 | |
| Disease | Bipolar Disorder | 5.65e-03 | 477 | 201 | 9 | C0005586 | |
| Disease | telomere length | 5.84e-03 | 313 | 201 | 7 | EFO_0004505 | |
| Disease | Benign neoplasm of stomach | 5.87e-03 | 17 | 201 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 5.87e-03 | 17 | 201 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 5.87e-03 | 17 | 201 | 2 | C0154060 | |
| Disease | sex interaction measurement, ulcerative colitis | 5.87e-03 | 17 | 201 | 2 | EFO_0000729, EFO_0008343 | |
| Disease | Adenomatous Polyposis Coli | 5.87e-03 | 17 | 201 | 2 | C0032580 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 5.87e-03 | 17 | 201 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Fetal Alcohol Syndrome | 5.87e-03 | 17 | 201 | 2 | C0015923 | |
| Disease | body weight | ADGRV1 RGP1 MEX3C FASN PTPRG UBIAD1 POLN DMD KSR2 POM121L2 MON1B BTN3A2 SLC2A2 UBE3D PAX2 SCRIB KDM4B | 5.92e-03 | 1261 | 201 | 17 | EFO_0004338 |
| Disease | sphingosine 1-phosphate measurement | 6.57e-03 | 18 | 201 | 2 | EFO_0800185 | |
| Disease | nevus count | 6.57e-03 | 18 | 201 | 2 | EFO_0004632 | |
| Disease | borna disease (biomarker_via_orthology) | 6.57e-03 | 18 | 201 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | testosterone measurement | SOX15 PCYT1A DCDC1 ERCC6L TRPM2 FBXO38 FASN PTPRG DSCAM KNSTRN ZBTB7B UBE3D SLC28A1 TNKS1BP1 GREB1 SLC24A1 PRLR | 6.58e-03 | 1275 | 201 | 17 | EFO_0004908 |
| Disease | polyp of colon | 6.62e-03 | 56 | 201 | 3 | MONDO_0021400 | |
| Disease | Early Pregnancy Loss | 6.67e-03 | 109 | 201 | 4 | C3830362 | |
| Disease | Spontaneous abortion | 6.67e-03 | 109 | 201 | 4 | C0000786 | |
| Disease | Miscarriage | 6.67e-03 | 109 | 201 | 4 | C4552766 | |
| Disease | Abortion, Tubal | 6.67e-03 | 109 | 201 | 4 | C0000822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STVWPTRLPTAASAS | 531 | P23470 | |
| PLIAAAVWSQRPFSD | 26 | A6NGE7 | |
| WRIFPVASASPSSSI | 61 | A8MUN3 | |
| ASSLEPAPSSQSIWF | 321 | Q14264 | |
| AAGLPWTSRTSPTVF | 586 | O95936 | |
| FSASGTQLSLRWEPP | 341 | P21709 | |
| EAFPSWSSRSPQERS | 56 | Q9H2A2 | |
| SIADPFFRSAQPWIA | 236 | O00478 | |
| DAQFTWVDAFPLSRP | 396 | Q8IX12 | |
| ASWPSRSLPAQEAVV | 131 | P35670 | |
| PSWSPSSLPFRTDNE | 501 | Q9H175 | |
| TASLLTFWNPPTTAK | 21 | P06731 | |
| AWDPLFGPSLDSSSS | 426 | Q0JRZ9 | |
| ANWVLTRNSTDPSPV | 431 | Q8WXG9 | |
| RPVNSWASDFNTLVP | 551 | Q9Y6B7 | |
| LAVPSAPSWAEFLSA | 1011 | O94983 | |
| FQTWPLTFLSPTDLA | 176 | Q13489 | |
| PLPEKTLASFSTQWS | 506 | Q8NFM4 | |
| PSFPSTLSWSRDESA | 561 | Q14161 | |
| SAPAASERPLWDTSL | 486 | O43299 | |
| TLINFWPVDSAPASS | 3411 | P11532 | |
| PRSREVQQSWPSTVF | 106 | Q96F25 | |
| KTFAPNTSLNSWDPI | 246 | Q8N865 | |
| IDLLPSPSAATNWTA | 331 | Q9H4D0 | |
| TDAAWSPVRPTVFFT | 411 | Q9GZS0 | |
| SPSSFWTSGLPRQER | 21 | A6NI87 | |
| SRLLSTPAWDSPANS | 1371 | Q9UKP4 | |
| IAAWLIDPSDATPSF | 351 | Q7Z5Q5 | |
| VASADPTPFVSWVRQ | 266 | Q8TDY8 | |
| STEATQWRPSLVPAS | 316 | Q14624 | |
| WASFTVPVPLATTAE | 546 | Q149M9 | |
| PPEANTKFNSRWTTD | 321 | Q8IZ40 | |
| ASGTTLLPQFRAPSW | 16 | Q2KHR3 | |
| SSEASLDTSWPRSRP | 556 | O75916 | |
| SQNATPTLWDSLEEP | 996 | Q68DA7 | |
| RSDLQFQPEEASPWT | 151 | Q96DU7 | |
| RPTALSPDYLSWTAS | 191 | Q99811 | |
| VSPWSSFPSDSLEFV | 716 | Q9HCM3 | |
| STSRLWSPAAPENSP | 71 | Q7L1V2 | |
| WTALRAAFPALSPAQ | 716 | Q96JH8 | |
| SRSPENPSWKSSLFV | 10001 | Q8WXI7 | |
| PLTTDTLLSDWPAAN | 401 | Q504Q3 | |
| AEWNPPLSFSLASRG | 111 | Q8N6Y1 | |
| SRSQIAPSILWPVAS | 686 | M0R2J8 | |
| ARAPARSPAWASTQA | 21 | Q8IZ02 | |
| RTLATSGPSFWLPQE | 306 | Q3ZCV2 | |
| PEPPAASSSFQARLW | 11 | Q6DN14 | |
| TDRPSSLGAWSLDPF | 1106 | Q9BY89 | |
| SRPPWVTDDSFSQKF | 486 | O75112 | |
| PASASTQTSWTPRDL | 131 | O95944 | |
| NLFPEVSIWITSRPS | 256 | Q7RTR2 | |
| TKAFTAAWSLRNPSP | 336 | O60721 | |
| AAWSLRNPSPRTSVS | 341 | O60721 | |
| SAAAPVTSAQLPWLA | 491 | Q4ZG55 | |
| SPSVMWASSFRPLLS | 1286 | Q4ZG55 | |
| WLPRPAISSESLADQ | 591 | A4FU01 | |
| LLDSPNPWLSSSVTA | 1261 | Q9P2D0 | |
| SRWIADPSPQNSTAD | 271 | P04035 | |
| TASLLTFWNPPTTAK | 21 | P40199 | |
| DSSSSPVDASKFPWR | 91 | Q8N7Q2 | |
| ANFSANTLSVPRWSP | 386 | Q6VAB6 | |
| RFFLPIPQQWDESSS | 416 | Q86X51 | |
| ASARGWFSSRPPTSE | 6 | Q9UK00 | |
| WASLPTAFPVDTTEL | 46 | P13224 | |
| VPELSVPSFSWRNRN | 316 | Q53F39 | |
| DPAWRSAVLANSPSL | 1896 | Q96RV3 | |
| VRNAPWTLTPEFLAE | 146 | P49585 | |
| SDSPRSWIQVQIPAS | 271 | Q96RD9 | |
| PGTPDFSDLLASWST | 231 | A0A1W2PR82 | |
| FWTSPSFKPNQIALT | 256 | A0A1B0GTH6 | |
| LDLLDSTNPPASAFW | 41 | A6NIU2 | |
| PRPAALAIAAFSNWT | 431 | P11168 | |
| TFESPEAFVALPRWS | 496 | Q9P2S2 | |
| RPTALTSPELSSWSA | 346 | O94953 | |
| SVSSWASSITVPRPF | 161 | Q96MY7 | |
| ASFDPSLQPSITWRG | 541 | P32004 | |
| EASLVWFTPPRTSNQ | 236 | Q9UHN1 | |
| PADSASFFPDLVWTL | 166 | Q96PP8 | |
| AATTAILIARSSPPW | 356 | P07093 | |
| LSFWINPDASAARVP | 286 | P48167 | |
| GLTASPADPTRTFAW | 2151 | Q9UMN6 | |
| NLSSEWSAPSDPLNI | 301 | Q6PI73 | |
| NLSSEWSAPSDPLNI | 301 | O75022 | |
| DATGFPTPQITWTRS | 276 | Q3SXY7 | |
| QEATTSAWSPSFLPA | 251 | Q9ULI3 | |
| FSDVRDPLQSPLWVT | 706 | Q32M88 | |
| WRVQSLPTSAPLSVS | 16 | Q6UWI2 | |
| SPWETSTSSFFPILA | 1306 | Q9UKK3 | |
| DTTWTPTRLASPLLA | 496 | C9JSJ3 | |
| SLLSAWRVSALPTPA | 501 | Q9NYZ3 | |
| NEAWRFSNPALLSSP | 381 | Q02962 | |
| ESFLWSTASPSPTLG | 266 | Q9UMZ3 | |
| RIFWNSFLISPVTPA | 76 | Q99706 | |
| SASPDATIRIWSVPN | 281 | Q9UMS4 | |
| PWLRSLRAAEPNSFA | 1106 | Q6PIJ6 | |
| WAFDSRKRPSFPNLT | 926 | P36888 | |
| TAAASTTEVPSRLPW | 131 | Q9NRJ2 | |
| LRTFPDPTSWYSSRS | 2441 | Q13535 | |
| INSATDPWPAFASSS | 76 | Q9P2N4 | |
| PFTNPRWATRVFAAE | 1211 | Q86XA9 | |
| FWRQRDLDSNPSPTT | 601 | Q8TE85 | |
| DWILATSAIPPSRLS | 651 | Q9BWV1 | |
| SLSLFAVWLEPADPN | 221 | Q9H227 | |
| SGRFSLPTWNKPDLS | 1466 | Q8WZ74 | |
| TPNFLANPSSSSRWI | 21 | Q7Z3S7 | |
| WSRSIEDLQPPSALS | 171 | Q8IVF7 | |
| LNFWKSPSSFNRPVD | 51 | Q9UI42 | |
| QERSSPASSIAWRTP | 136 | Q9H665 | |
| LPAAWSTFAYSLRPS | 291 | Q9H665 | |
| RSANAFLTPSYTWTP | 331 | Q15398 | |
| LESPWPSSTRSGIFL | 866 | Q5VZ89 | |
| FLPPSSFELWSSDRS | 561 | Q68DC2 | |
| SIADPFFRSAQPWIA | 236 | P78410 | |
| SNTPLLPSFEIGAWT | 326 | Q9NYL2 | |
| DSSWAPKRVATASPF | 1176 | O60336 | |
| VLSWEPVALSNSTRP | 46 | P38484 | |
| SPIFLPVDDTSFRWV | 1411 | P49327 | |
| TSAFSLISPAWFQTP | 16 | Q6ICI0 | |
| TTIRFTWNAPSPQFI | 806 | Q58EX2 | |
| DALFPSVAPQDFWRS | 46 | Q9Y2W3 | |
| SSWGDLLPVLTPSAF | 431 | Q9H7H0 | |
| LSAVPQSFSPSLRSW | 21 | O95965 | |
| VTDLDAPNSPAWRAT | 351 | P22223 | |
| SPFLAEVLSEPWRLS | 671 | Q92523 | |
| TAATRVVIFDPSWNP | 546 | Q2NKX8 | |
| TWNLVSPDSPRSIDS | 1036 | P42702 | |
| VSADEVNSPLSPLTW | 511 | Q5VUJ6 | |
| TWLPDNQFTDARTEP | 106 | P18433 | |
| PPLRFQTFSAVRNTW | 21 | Q9NUT2 | |
| VRNATFTWARSDPPT | 646 | P33527 | |
| FTWARSDPPTLNGIT | 651 | P33527 | |
| RAISPDSPISQSWAE | 61 | P07332 | |
| SEQWGSFPISPSERS | 1421 | O60469 | |
| DASSWQPPADLSALS | 796 | Q75VX8 | |
| SAAAWPPSASAALNS | 266 | Q12946 | |
| ASALRSSPWTETAAP | 261 | C9JL84 | |
| ESPSFSWRTQIDSPL | 341 | P19320 | |
| SWSPDVFSLPLRICS | 111 | P0C7P3 | |
| ESNAFLPSSVLWLSP | 236 | Q96R06 | |
| EPPTLAQPSRWSSNF | 251 | Q9H2G2 | |
| DTLPSWLNAPAFVAA | 216 | O95754 | |
| LELLSSWFSPPTVVA | 196 | Q14C87 | |
| ISWSYRPEPTNSSLN | 41 | P12259 | |
| PPTATSASSEALAWA | 31 | Q92546 | |
| QVGSRPTSWALFELP | 776 | A1L390 | |
| IPESWRSEVTFSTPA | 206 | O14975 | |
| TWESQRQDSDALPSP | 531 | P27987 | |
| PLEWNTSLAPSAFES | 56 | Q5T2S8 | |
| TASLLNFWNPPTTAE | 21 | Q00887 | |
| DLFWSPLEATVSAPS | 601 | O14594 | |
| SPAFDSLPTSAQTIW | 496 | Q5U5Q3 | |
| FSEAAQTPLWKPQSS | 246 | Q96QH2 | |
| FTLSPSPQDWRDTLF | 326 | Q9NPR2 | |
| APPLDRVFRTTWLST | 6 | Q9Y448 | |
| SWASEPERPSILSAS | 286 | Q9Y520 | |
| LTFSWTGNALSPLDP | 176 | O15389 | |
| SSNALPQSLPAWRSS | 216 | P17861 | |
| FSTPPVSTFDWVRAE | 331 | Q9NY99 | |
| SWLASTPRSTYDLSP | 61 | Q7Z3Z2 | |
| PSTRITPEFSKWASD | 441 | Q5VTB9 | |
| TWSDAPPSRVSVIQF | 436 | Q14160 | |
| QPSADRASSLSRPWE | 231 | Q53GL0 | |
| KLPSPFSLLNSDSSW | 671 | Q8IUC4 | |
| SPLPASALVSTNWLA | 726 | Q96KW2 | |
| LSAFRPWSPAVSASE | 376 | P12755 | |
| DWLFSADVSRPPGST | 591 | Q9UL12 | |
| TDTSWLVPATPLASR | 1251 | Q8IY92 | |
| ENEPLRGFSWLSSDP | 106 | Q86T13 | |
| LNRPFSSKWSTANPS | 331 | O75122 | |
| WPESILPIDQASFAS | 1036 | Q15596 | |
| RFTLWASSAPPLSEL | 1221 | Q99570 | |
| APATTSSWEPRRAST | 651 | O00562 | |
| TEITSSGFRLAWPPL | 221 | Q6PCB0 | |
| SSQDQAWSLEPPAAT | 6 | O60248 | |
| ASTLSIWDLAAPTPR | 551 | Q04724 | |
| TLSAPNATTPWLGRD | 16 | P47901 | |
| ASWGFPDASSTVPSL | 46 | Q96NJ1 | |
| PWSFASSFRPAASPL | 71 | Q8N2B8 | |
| LSLARFWEQSAPTGP | 496 | O15156 | |
| PSTPLRWTVFSSSVA | 86 | Q969K7 | |
| WVASAPEAPLQSSET | 216 | Q13064 | |
| PRSQVDPTSANFLIW | 106 | P04085 | |
| ALPAWRPLTTSASLT | 391 | Q0P670 | |
| EAVSTPNTPRNLAAW | 551 | Q9Y5W7 | |
| AVAASPFPAWRRDNT | 11 | Q8N2H3 | |
| PQPSRETALLTTAAW | 321 | Q8WTU2 | |
| SDATQQRPAFPEWLT | 1011 | O94759 | |
| SIPLSAFWSADPSVS | 656 | Q5VZP5 | |
| PQAVFSTSSRFWSSP | 151 | Q99594 | |
| STSSRFWSSPPLLGQ | 156 | Q99594 | |
| PSAAASVPVWQDRTI | 206 | Q99594 | |
| SSERSFPIIPRSWFV | 236 | Q7Z6J8 | |
| RPAISPENFLSASWT | 496 | Q9P2H5 | |
| SLSQSFEWTFPTRPS | 471 | Q9C0C2 | |
| TGSSPDSLSLFWTVP | 1381 | P22105 | |
| SAWSPATFIQIPSDF | 216 | P16471 | |
| WANTSPEAELFPALR | 471 | Q12899 | |
| SPAVSRTQLASWSDP | 4396 | Q15149 | |
| SPFWQDTAFITLSPK | 556 | O43548 | |
| TSSLRLNWEAPPGAF | 156 | Q16473 | |
| LALRPWSFSASLTPV | 51 | Q9Y5Z9 | |
| TDSLPADWAPLFTNA | 301 | P27708 | |
| EIRSSWSEAAPKPFS | 46 | O00337 | |
| REPTALSSSLAPTWL | 366 | Q6EMK4 | |
| SWQPSILPDGSIFSR | 1181 | Q9UBW7 | |
| FSTPPSQAAWRTLLT | 21 | Q5W150 | |
| SSQCWSLPAIVRPEF | 3196 | Q7Z7G8 | |
| SVNWSAPSQAFPRIT | 956 | Q9BTW9 | |
| NTGTPLRVLPSVFWS | 46 | Q5PR19 | |
| SDSAPVWSLPTSLLT | 1081 | Q14679 | |
| TSAFFPNIWSLLAAP | 26 | Q9Y334 | |
| SQTSAWPLYRAPSAL | 21 | P01282 | |
| ESSPRPSFWERSHLA | 126 | O60293 | |
| LTFSWTGNALSPLDP | 176 | Q08ET2 | |
| SISPWLARRTSPANS | 166 | Q86UZ6 | |
| PPGRASRFLQSISWD | 236 | Q9H808 | |
| TSRPGRTSDSPWFLS | 101 | O95071 | |
| FRVPPVSTAATWQSS | 186 | P78423 | |
| APSFSWTGAALSPRR | 176 | A6NMB1 | |
| RAPDTLTTVFFPASW | 376 | Q96P71 |